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PCardiac Imaging
Prognostic Significance of
Myocardial Fibrosis Quantification by
Histopathology and Magnetic Resonance
Imaging in Patients With Severe Aortic Valve Disease
Clerio F. Azevedo, MD, Marcelo Nigri, MD, Maria L. Higuchi, MD, Pablo M. Pomerantzeff, MD,
Guilherme S. Spina, MD, Roney O. Sampaio, MD, Fla´vio Tarasoutchi, MD, Max Grinberg, MD,
Carlos Eduardo Rochitte, MD
São Paulo, Brazil
Objectives We sought to determine whether the quantitative assessment of myocardial fibrosis (MF), either by histopathol-
ogy or by contrast-enhanced magnetic resonance imaging (ce-MRI), could help predict long-term survival after
aortic valve replacement.
Background Severe aortic valve disease is characterized by progressive accumulation of interstitial MF.
Methods Fifty-four patients scheduled to undergo aortic valve replacement were examined by ce-MRI. Delayed-enhanced
images were used for the quantitative assessment of MF. In addition, interstitial MF was quantified by histologi-
cal analysis of myocardial samples obtained during open-heart surgery and stained with picrosirius red. The ce-
MRI study was repeated 27  22 months after surgery to assess left ventricular functional improvement, and all
patients were followed for 52  17 months to evaluate long-term survival.
Results There was a good correlation between the amount of MF measured by histopathology and by ce-MRI (r  0.69,
p  0.001). In addition, the amount of MF demonstrated a significant inverse correlation with the degree of left
ventricular functional improvement after surgery (r  0.42, p  0.04 for histopathology; r  0.47, p  0.02
for ce-MRI). Kaplan-Meier analyses revealed that higher degrees of MF accumulation were associated with worse
long-term survival (chi-square  6.32, p  0.01 for histopathology; chi-square  5.85, p  0.02 for ce-MRI). On
multivariate Cox regression analyses, patient age and the amount of MF were found to be independent predic-
tors of all-cause mortality.
Conclusions The amount of MF, either by histopathology or by ce-MRI, is associated with the degree of left ventricular func-
tional improvement and all-cause mortality late after aortic valve replacement in patients with severe aortic
valve disease. (J Am Coll Cardiol 2010;56:278–87) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.12.074o
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Nevere aortic valve disease is characterized by progressive
ccumulation of interstitial myocardial fibrosis (MF) and
mpairment of myocyte ultrastructure (1–4). Previous stud-
es have shown that the amount of MF and the degree of
yocyte degeneration are inversely related to both systolic
1) and diastolic (5,6) left ventricular (LV) function. Yet,
he few studies that investigated the relationship between
nterstitial MF and LV functional recovery after aortic valve
eplacement have reported conflicting results (1,2). More-
ver, the prognostic significance of interstitial MF in terms
rom the Heart Institute (InCor), University of São Paulo Medical School, São
aulo, Brazil.b
Manuscript received August 25, 2009; revised manuscript received November 16,
009, accepted December 17, 2009.f long-term survival after aortic valve replacement remains
o be demonstrated.
See page 288
In recent years, contrast-enhanced magnetic resonance
maging (ce-MRI) with the delayed-enhancement tech-
ique has been shown to provide an accurate assessment of
yocardial necrosis and fibrosis, not only in the setting of
yocardial infarction (7–10) but also in a variety of other
onischemic cardiomyopathies (11–14). Unlike histopa-
hology, ce-MRI is not able to evaluate interstitial MF at
he microscopic level due to insufficient spatial resolution.
evertheless, although widespread and diffuse, the distri-ution of interstitial MF in chronic aortic valve disease can
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July 20, 2010:278–87 Myocardial Fibrosis in Aortic Valve Diseasee regionally accentuated (4,15). Therefore, we hypothe-
ized that there would be a relationship between the degree
f diffuse interstitial MF by histopathology and the preva-
ence of focal regions of accentuated MF that could be
dentified by ce-MRI.
In the present study we sought to determine whether the
mount of MF measured by ce-MRI demonstrated good
orrelation when compared with the gold-standard his-
opathological analyses. Additionally, we attempted to deter-
ine whether the quantitative assessment of MF, either by
e-MRI or by histopathology, could help predict LV func-
ional improvement and long-term survival after aortic valve
eplacement surgery.
ethods
atients. Fifty-four patients with severe aortic valve disease
nd indication for aortic valve replacement were prospec-
ively enrolled between May 2001 and May 2003. All
atients over 40 years old had a coronary angiography, and
hose with significant coronary artery disease (CAD) (lumi-
al stenosis 50%) were excluded. Patients with concomi-
ant mitral valve disease were also excluded. In addition,
here were 2 distinct control groups: 8 subjects who died of
oncardiac causes and had no previous history of cardiovas-
ular disease served as control subjects for the quantitative
istological analyses; and 10 normal volunteers served as
ontrol subjects for the quantitative ce-MRI analyses. The
tudy was approved by the Institutional Ethics Committee,
nd all patients gave written informed consent.
issue sampling and histological analyses. During open-
eart surgery, 0.8-cm-thick myectomy samples weighing 25
o 70 mg were obtained from the basal LV septum approx-
mately 2 cm below the base of the commissure between the
ight and left aortic cusps. For each patient, 5 paraffin-
mbedded sections were stained with picrosirius red (16).
he regions of interstitial MF were determined by quanti-
ative video-morphometry with an automated image analy-
is system (Quantimet 520 Image Analysis System, Cam-
ridge Instruments, Cambridge, United Kingdom). For
ach patient, quantification of interstitial MF was per-
ormed on 12 different fields representative of all myocardial
ayers sampled. Patients were categorized into 3 groups:
roup 1, patients with MF 20%; Group 2, patients with
F between 20% and 30%; and Group 3, patients with
F 30%.
agnetic resonance imaging (MRI) protocol. Patients
nderwent cardiac MRI with a 1.5-T clinical scanner (Signa
V/I, GE Medical Systems, Waukesha, Wisconsin). After
ocalization of the heart, 8 to 12 contiguous short-axis slices
ncompassing the entire LV and 4 long-axis slices were
rescribed. Cine images were acquired with a steady-state
ree precession pulse sequence. Delayed-enhancement im-
ges were acquired 5 to 15 min after a bolus injection of 0.2
mol/kg gadoterate meglumine (Dotarem, Guerbet,
ulnay-sous-Bois, France), with an inversion recovery fast cradient-echo pulse sequence (8).
he inversion time was adjusted
n the basis of the visual inspec-
ion of the images by an experi-
nced investigator to null the sig-
al of the normal myocardium
8,17). Additionally, to evaluate
he effect that the interval be-
ween contrast administration
nd image acquisition could have
n MF quantification, a second
et of delayed-enhancement im-
ges was acquired in a subgroup of
0 patients. The first and second
ets of delayed-enhancement im-
ges were acquired 12  4 min
nd 21  9 min after contrast
dministration, respectively.
RI data analyses. All MRI
mage analyses were performed
ith the custom software package Cinetool (GE Medical
ystems, Waukesha, Wisconsin). Cine images were used for
he assessment of LV volumes, mass, and function (17).
uantification of MF by ce-MRI was based on the assess-
ent of the short-axis delayed-enhanced images. The re-
ions of MF were defined as the sum of pixels with signal
ntensity (SI) above a pre-determined threshold. The defi-
ition of this threshold was based on 3 parameters: 1) the
ean SI of total myocardium; 2) the SI variability from an
rea of nondiseased myocardium free of focal regions of
F, which was calculated as 2 SDs of mean SI of a remote
rea; and 3) the SI variability that could be introduced by
he image noise of the delayed-enhancement dataset, which
as calculated as 2 SDs of mean SI of air. More specifically,
he threshold was calculated as: mean SI of total myocar-
ium 2 SDs of mean SI of a remote area 2 SDs of mean
I of air.
First, the endocardial and epicardial LV borders were
anually contoured, and the mean SI of total myocardium
as automatically calculated by the software. Then, the
nvestigator delineated a remote area in a myocardial region
ree of any hyperenhancement and a region of interest in the
ir outside the patient. After these steps, the threshold value
as determined, and the software automatically calculated
he area of all pixels within the myocardium with SI above
his cutoff value. The amount of MF was expressed as a
ercentage of LV mass, and patients were categorized into
groups: Group 1, patients with MF 2.5%; Group 2,
atients with MF between 2.5% and 5.0%; and Group 3,
atients with MF 5.0%. Additionally, interobserver and
ntraobserver variability were measured in a subgroup of 20
atients. The delayed-enhancement dataset was also quali-
atively evaluated for the presence of MF by the visual
nspection of the images as previously described (17).
tatistical analysis. Student t tests were used to compare
Abbreviations
and Acronyms
CAD  coronary artery
disease
ce-MRI  contrast-
enhanced magnetic
resonance imaging
CI  confidence interval
EF  ejection fraction
HR  hazard ratio
LV  left ventricle/
ventricular
MF  myocardial fibrosis
MRI  magnetic resonance
imaging
NYHA  New York Heart
Association
SI  signal intensityontinuous variables, which were expressed as mean  SD.
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Myocardial Fibrosis in Aortic Valve Disease July 20, 2010:278–87isher exact test was used to compare categorical variables.
inear regression analyses were used to assess: 1) the
orrelation between the values of MF measured by histopa-
hology and by ce-MRI; and 2) the relationship between the
mount of MF and the degree of LV functional improve-
ent after surgery. The Kaplan-Meier technique was used
o evaluate survival times after surgery, and the log-rank test
as used to compare survival curves. Cox regression was
sed to examine the effects of several continuous and
ategorical predictors of patient mortality. All tests were
-tailed, and a value of p  0.05 was considered indicative
f statistical significance.
esults
aseline characteristics. Patient baseline characteristics
re summarized in Table 1. All patients were symptomatic,
omplaining of exertional dyspnea (94%), angina (24%),
nd/or syncope (9%). Among patients with predominant
ortic stenosis (n  28), 6 also exhibited moderate aortic
egurgitation, and among patients with predominant
Pre-Operative Characteristics of the 54 PatientsTable 1 Pre-Operative Characteristics of the
All
(n  54)
Sex
Male 42 (78%)
Female 12 (22%)
Age (yrs) 46.8 13.7
Etiology
Rheumatic disease 27 (50%)
Bicuspid aortic valve 18 (33%)
Degenerative/calcification 6 (11%)
Other 3 (6%)
NYHA functional class
I 3 (5%)
II 22 (41%)
III 29 (54%)
Angina 13 (24%)
Syncope 5 (9%)
Pressure gradient (mm Hg)
Peak —
Mean —
Hypertension 0
Diabetes 0
Hypercholesterolemia 0
Smoking 2 (4%)
Family history of CAD 0
LV EDV (ml) 244 92
LV ESV (ml) 124 67
LV mass (g) 272 47
LVEF (%) 51 11
MF by histopathology (%) 24.6 9.8
MF by ce-MRI (%) 3.72 2.17
MF by qualitative analysis
Present 35 (65%)
Absent 19 (35%)CAD  coronary artery disease; ce-MRI  contrast-enhanced magnetic reso
ESV  end-systolic volume; LV  left ventricular; MF  myocardial fibrosis; Nortic insufficiency (n  26), 2 also exhibited moderate
ortic stenosis. All patients underwent surgical aortic valve
eplacement. Due to difficulty in achieving an adequate
onitoring of anticoagulant therapy in our population, all
atients received biological prosthetic valves. The baseline
haracteristics of the control groups are summarized in
able 2.
nterstitial MF by histopathology. The amount of inter-
titial MF determined by histopathology was higher in
atients with aortic valve disease than in control subjects
24.6  9.8% vs. 6.0  1.8%, p  0.001). Patients with
ortic regurgitation and aortic stenosis exhibited similar
egrees of interstitial MF accumulation (25.8  10.3% vs.
3.4  9.3%, p  0.37).
F by ce-MRI. The amount of MF measured by ce-MRI
as also higher in patients with aortic valve disease than in
ontrol subjects (3.72  2.17% vs. 0.57  0.55%, p 
.001). Patients with aortic regurgitation exhibited higher
F accumulation than those with aortic stenosis (4.35 
.32% vs. 3.15  1.87%, p  0.04). There was good
atients
Regurgitation
(n  26)
Aortic Stenosis
(n  28) p Value
4 (92%) 18 (64%) 0.02
2 (8%) 10 (36%)
6.5 14.2 47.2 13.5 0.85
0 (77%) 7 (25%) 0.001
3 (11.5%) 15 (54%)
0 6 (21%)
3 (11.5%) 0
2 (8%) 1 (4%) 0.79
0 (38%) 12 (43%)
4 (54%) 15 (53%)
3 (12%) 10 (36%) 0.04
1 (4%) 4 (14%) 0.18
— 97 27 —
— 63 20 —
0 0 —
0 0 —
0 0 —
1 (4%) 1 (4%) 1.0
0 0 —
18 68 175 43 0.001
69 67 83 30 0.001
80 44 266 50 0.27
48 11 53 9 0.09
5.8 10.3 23.4 9.3 0.37
.35 2.32 3.15 1.87 0.04
8 (69%) 17 (61%) 0.51
8 (31%) 11 (39%)54 P
Aortic
2
4
2
1
1
3
1
2
2
4
1nance imaging; EDV  end-diastolic volume; EF  ejection fraction;
YHA  New York Heart Association.
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July 20, 2010:278–87 Myocardial Fibrosis in Aortic Valve Diseasegreement of MF measurements in the 20 patients in whom
second set of delayed-enhancement images was acquired,
ith a mean difference of 0.10% (95% confidence interval
CI]: 0.29% to 0.49%, limits of agreement 1.55% to
.75%). In addition, interobserver and intraobserver repro-
ucibility was very good, with a mean difference of 0.02%
95% CI:0.23% to 0.19%, limits of agreement0.91% to
.88%) and 0.03% (95% CI: 0.15% to 0.21%, limits of
greement 0.74% to 0.79%), respectively.
Most patients exhibited a pattern of delayed-enhancement
hat was multifocal (3 or more foci of MF) and widespread: 21
atients (81%) with aortic regurgitation, and 20 (72%) with
ortic stenosis (Fig. 1). The LV sites of myocardial involve-
ent were highly variable. In general, any portion of the LV
alls could be affected by the focal accumulation of MF. The
attern and location of MF accumulation was similar in
atients with aortic regurgitation and aortic stenosis.
We were able to identify regions of MF by the qualitative
isual assessment of the delayed-enhanced images in 35
atients (64%). In 17 patients, the quantitative semi-
utomatic analysis revealed small regions of focal MF that
ould not be detected by the visual assessment. Patients with
isually identified regions of MF demonstrated higher
mounts of MF on the quantitative analyses, both by
istopathology (29.1  8.0% vs. 16.2  6.9%, p  0.0001)
nd by ce-MRI (4.6  2.0% vs. 2.2  1.6%, p  0.0001).
elationship between histopathology and ce-MRI.
uantification of MF by ce-MRI with the technique
escribed in the present study showed good correlation with
he measurements obtained by histopathology (r  0.69,
 3.10x  13.0, p  0.001) (Figs. 2 and 3). Correlation
as also good if considering only the subgroup of patients
ith aortic regurgitation (r  0.70, y  3.09x  12.3, p 
.001) or aortic stenosis (r  0.67, y  3.34x  12.9, p 
.001).
V functional changes over time. All analyses performed
o evaluate LV changes over time included only the 25
Baseline Characteristics of Control Groups andTable 2 Baseline Characteristics of Control
Patients
(n  54)
Hist
Sex
Male 42 (78%)
Female 12 (22%)
Age (yrs) 46.8 13.7 33
MF by histopathology (%) 24.6 9.8 6
MF by ce-MRI (%) 3.72 2.17
MF by qualitative analysis
Present 35 (65%)
Absent 19 (35%)
Eight subjects who died of noncardiac causes and had no previous his
histological analyses. Ten normal volunteers served as control subject
p values are for control subjects versus patients.
MF  myocardial fibrosis.atients that underwent a second MRI study 27  22 honths after aortic valve replacement. The reasons for the
emaining patients to not undergo the follow-up MRI
ncluded patient refusal, contact loss, place of residence too
istant, death, and placement of a definitive pacemaker.
There was a significant reduction of LV mass between
oth studies (261  54 g vs. 179  52 g, p  0.0001).
lthough the amount of MF measured by ce-MRI did not
how a significant change when expressed as a percentage of
V mass (3.13  2.18% vs. 3.10  2.63%, p  0.93), it
xhibited a significant reduction when expressed as total LV
brous content in grams (8.9  8.0 g vs. 5.8  6.7 g, p 
.005).
There was a significant increase of LV ejection fraction
EF) between both studies (54  10% vs. 59  14%, p 
.02). The amount of MF, either by histopathology or by
e-MRI, exhibited a moderate inverse correlation with the
agnitude of LVEF change over time (r0.42, p 0.04
or histopathology; r  0.47, p  0.02 for ce-MRI). In
ther words, the higher the amount of MF, the worse was
he improvement of global LV systolic function after aortic
alve replacement (Figs. 4A and 4B).
rognostic significance. Patients were followed for 52 
7 months after aortic valve replacement (range 10 to 72
onths). Two patients (3.7%) were lost during follow-up.
ixteen patients died 21 21 months after surgery (ranging
rom 4 days to 62 months). There were 4 deaths in the early
30 days) and 12 deaths in the late (30 days) post-
perative period. Deaths were due to progressive heart
ailure (n  6), sudden death (n  5), post-operative
omplications (n  3), infective endocarditis (n  1), and
emorrhagic cerebrovascular accident (n  1). There were
o deaths during the surgical procedure. Two patients
equired reoperation for replacement of the prosthetic valve
ue to infective endocarditis. Clinical and laboratory data
omparing patients that died or survived are summarized in
able 3.
aplan-Meier analyses. The amount of interstitial MF by
arison With Study Populationps and Comparison With Study Population
Control Groups
logy
) p Value
Ce-MRI
(n  10) p Value
) 0.09 7 (70%) 0.59
) 3 (30%)
0.0 0.01 43.1 11.8 0.42
.8 0.001 —
0.57 0.55 0.001
0 (0%) 0.001
10 (100%)
cardiovascular disease served as control subjects for the quantitative
e contrast-enhanced magnetic resonance imaging (ce-MRI) analyses.CompGrou
opatho
(n  8
4 (50%
4 (50%
.5 1
.0 1
—
—
—
tory of
s for thistopathology was significantly higher in the subgroup of
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Myocardial Fibrosis in Aortic Valve Disease July 20, 2010:278–87atients that died during follow-up than in those that
urvived (29.5  7.6% vs. 22.5  9.9%, p  0.01).
aplan-Meier analyses revealed that patients with a higher
mount of interstitial MF by histopathology demonstrated
ignificantly lower survival probabilities (log-rank test chi-
quare  6.32, p  0.01) (Fig. 4C). Similarly, the amount
f MF by ce-MRI was higher in the subgroup that died
han in those that survived (4.93 2.16% vs. 3.22 1.98%,
 0.01). Patients with higher amount of MF by ce-MRI
lso demonstrated significantly lower survival probabilities
log-rank test chi-square  5.85, p  0.02) (Fig. 4D).
When we considered the qualitative assessment, 13 pa-
ients (37%) with visually identified MF and 3 patients
16%) without any MF on the visual assessment died during
ollow-up. Although the difference between the survival
urves was not statistically significant, there was a trend
Figure 1 Delayed-Enhanced MRI From Different Patients With S
Examples from patients with aortic stenosis (A, C, D) and aortic regurgitation (B,
Example from a patient with aortic stenosis that did not have any region of identifi
showing that the regions of MF identified on the short-axis images (H) could alsooward higher mortality in the subgroup with visually sdentified regions of MF (log-rank test chi-square  1.89,
 0.17).
ox regression analyses. In addition to the amount of
F, several well-established predictors of all-cause mortal-
ty after aortic valve replacement surgery—namely, patient
ge, resting LVEF, New York Heart Association (NYHA)
unctional class, and patient diagnosis (aortic regurgitation
r aortic stenosis)—were evaluated by Cox proportional
azards regression analyses (Table 4). Two distinct multi-
ariable analyses were performed; the first included the
mount of interstitial MF by histopathology, and the second
ncluded the amount of MF by ce-MRI. When all of the
forementioned variables were considered in the first mul-
ivariable model with stepwise backward selection, MF by
istopathology (hazard ratio [HR]: 1.07; p  0.017) and
atient age (HR: 1.04, p  0.045) emerged as the 2
e Aortic Valve Disease
howing several foci of myocardial fibrosis (MF) accumulation (thin arrows). (G)
F by contrast-enhanced magnetic resonance imaging (MRI). Illustrative images
alized on the orthogonal long-axis views (I) (thick arrows).ever
E, F) s
able M
be visutrongest independent predictors of all-cause mortality. If
w
M
t
o
a
r
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July 20, 2010:278–87 Myocardial Fibrosis in Aortic Valve Diseasee considered only patients with late mortality (30 days),
F by histopathology remained as an independent predic-
or of mortality (HR: 1.06, p  0.04), but patient age was
Figure 2 Linear Regression Graph
Note that there was a good correlation between the amount of myocardial fibrosis me
Figure 3 Selected Examples Illustrating the Correlation Betwee
Delayed-enhanced image from a patient with severe aortic stenosis that exhibited
imaging (ce-MRI) (0.80%) (A) and the histopathological specimen from the same p
histopathology (12.6%) (B). Delayed-enhanced image from a patient with severe a
the histopathological specimen from the same patient showing a large amount off borderline significance (HR: 1.04, p  0.06). When we
pplied stepwise backward selection on the second multiva-
iable model, the amount of MF by ce-MRI stood as an
by histopathology and by contrast-enhanced magnetic resonance imaging (ce-MRI).
F by Histopathology and by ce-MRI
ll amount of myocardial fibrosis (MF) by contrast-enhanced magnetic resonance
stained with picrosirius red showing a small amount of interstitial fibrosis by
gurgitation that exhibited extensive regions of MF by ce-MRI (9.44%) (C), and
itial MF by histopathology (42.7%) (D).asuredn M
a sma
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Myocardial Fibrosis in Aortic Valve Disease July 20, 2010:278–87ndependent predictor of all-cause mortality (HR: 1.26, p
.027), and patient age was of borderline significance (HR:
.04, p  0.054). If we considered only patients with late
ortality (30 days), the results were similar: MF by
e-MRI remained as an independent predictor of mortality
HR: 1.25, p  0.05), and patient age was of borderline
ignificance (HR: 1.04, p  0.07). It is important to
ighlight that, due to the relatively small number of events
16 deaths), there is a degree of overfitting in our multivar-
ate Cox regression models.
iscussion
n the present study we were able to demonstrate that
e-MRI allows for the noninvasive quantification of MF in
atients with severe aortic valve disease. The amount of MF
easured by ce-MRI demonstrated good correlation with
he values of interstitial MF obtained by the gold-standard
Figure 4 Relationship Between the Amount of MF and LV Func
and Long-Term Survival After Aortic Valve Replacemen
Relationship between the amount of myocardial fibrosis (MF) and left ventricular (L
valve replacement surgery. Linear regression graphs illustrating the relationship be
netic resonance imaging (ce-MRI) (B), and the degree of LV functional improvemen
survival probabilities of the subgroups with increasing amounts of MF. Note that p
MRI (D), demonstrated significantly lower survival probabilities after aortic valve reistopathological analyses. Most importantly, this was the drst study to demonstrate that the quantitative assessment
f MF, either by histopathology or by ce-MRI, provides
mportant and independent prognostic information in this
atient population.
F in severe aortic valve disease. Previous studies that
sed histopathology to investigate the process of chronic
yocardial injury in patients with severe aortic valve disease
ave demonstrated that it is characterized by a significant
ncrease of interstitial MF and by variable degrees of
yocyte degeneration (1–4). The pathophysiological mech-
nisms involved include the excessive activation of the
ardiac renin-angiotensin system (18), the over-expression
f myocardial neutral endopeptidase with inhibition of the
allikrein-kinin system (19) and the increased expression of
issue inhibitor of metalloproteinase 1 and 2 (5). Our
nding that the amount of interstitial MF by histopathology
as significantly higher in patients with severe aortic valve
l Improvement
rgery
ctional improvement (A and B) and long-term survival (C and D) after aortic
the amount of MF, either by histopathology (A) or by contrast-enhanced mag-
22 months after aortic valve replacement. Kaplan-Meier graphs comparing the
with higher degrees of MF accumulation, either by histopathology (C) or by ce-
ent. EF  ejection fraction.tiona
t Su
V) fun
tween
t 27 
atients
placemisease than in control subjects (24.6% vs. 6.0%) is in
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July 20, 2010:278–87 Myocardial Fibrosis in Aortic Valve Diseasegreement with previous reports by Hein et al. (1) (31% vs.
1%) and by Heymans et al. (5) (16% vs. 7%).
he assessment of MF by ce-MRI. In addition to histo-
athology, in the present study we also used ce-MRI to
uantify the regions of MF. A previous study by Moon et al.
12) also compared ce-MRI and histopathology regarding
he quantitative assessment of MF. In that study, they
valuated the entire heart of a single patient with hypertro-
hic cardiomyopathy that had to undergo heart transplan-
ation. One of their main findings was that LV segments
ith 15% interstitial MF by histopathology demonstrated
higher likelihood of exhibiting regions of MF by ce-MRI
n a visual subjective analysis. Moreover, their quantitative
nalyses revealed a significant correlation between intersti-
ial MF by histopathology and the amount of MF by
e-MRI (r  0.70) (12). In agreement with Moon et al.
haracteristics of Subgroupst Died or Survived During Follow-UpTable 3 Characteristics of SubgroupsThat Died or Survived During Follow-Up
Deceased
(n  16)
Survivors
(n  38) p Value
Sex
Male 10 (62%) 32 (84%) 0.15
Female 6 (38%) 6 (16%)
Age (yrs) 51.1 14.9 45.0 13.0 0.14
Diagnosis
Aortic regurgitation 10 (62%) 16 (42%) 0.23
Aortic stenosis 6 (38%) 22 (58%)
NYHA functional class
I 1 (6%) 2 (5%) 0.02
II 2 (13%) 20 (53%)
III 13 (81%) 16 (42%)
LV EDV (ml) 280 92 229 88 0.06
LV ESV (ml) 156 76 111 59 0.02
LV mass (g) 285 45 267 48 0.20
LV EF (%) 46 12 53 9 0.01
MF by histopathology (%) 29.5 7.6 22.5 9.9 0.01
MF by ce-MRI (%) 4.93 2.16 3.22 1.98 0.01
MF by qualitative analysis
Present 13 (81%) 22 (58%) 0.10
Absent 3 (19%) 16 (42%)
bbreviations as in Table 1.
Univariable and Multivariable Associations WithTable 4 Univariable and Multivariable Assoc
Variable
Univariable Analysis
Unadjusted HR
(95% CI) p Value
Age 1.03 (0.99–1.07) 0.07
Patient diagnosis 1.82 (0.66–5.02) 0.25
LVEF 0.95 (0.91–0.99) 0.02
NYHA functional class 2.76 (0.95–8.05) 0.06
MF by histopathology 1.06 (1.01–1.11) 0.02
MF by ce-MRI 1.24 (1.02–1.50) 0.03
Both multivariable models included age, LVEF, and NYHA functio
histopathology, and the second multivariable model included the amount of
CI  confidence interval; HR  hazard ratio; other abbreviations as in Tabl12), we also found a significant correlation between histo-
athology and ce-MRI (r  0.69).
Previous studies by our group (17) and others (15,20,21)
ave demonstrated that it is possible to identify focal regions
f MF in patients with severe aortic valve disease with
e-MRI. However, in these studies the assessment of MF
as based on the visual subjective inspection of the delayed-
nhanced images, whereas in the present study we employed
semiautomatic algorithm that allowed for the objective
uantification of MF. In addition, whereas the former were
bservational studies, the present is a longitudinal study that
ollowed patients for 4.3  1.4 years and was able to
emonstrate an association between MF and long-term
urvival in this population. Previous prospective trials have
lso demonstrated the prognostic significance of delayed-
nhancement in patients with nonischemic cardiomyopathy
22,23). Our results are in agreement with these previous
eports and indicate that it is possible that the prognostic
ignificance of MF assessment by ce-MRI might be broadly
pplicable to other nonischemic cardiomyopathies charac-
erized by chronic myocardial injury.
As previously mentioned, the present study has a
imitation regarding the spatial resolution of ce-MRI.
ith a typical voxel dimension of approximately 1.4 
.9  8.0 mm, ce-MRI is not currently able to evaluate
nterstitial MF at the microscopic level as histopathology
oes. Therefore, even though both methods are evaluat-
ng the same pathophysiological process (i.e., the patho-
ogical accumulation of MF), they are actually measuring
distinct parameters. Although histopathology directly
easures the fraction of myocardial tissue occupied by
nterstitial fibrosis (reactive fibrosis), ce-MRI only quan-
ifies the LV regions in which there is a focal accumula-
ion of MF (replacement fibrosis). It is important to note,
owever, that histopathology is limited to the assessment
f small myocardial samples obtained through surgical
yectomy or endomyocardial biopsy, whereas ce-MRI
nables the complete assessment of the entire LV. Newer
RI techniques especially designed for the assessment of
iffuse interstitial fibrosis accumulation, such as myocar-
ium T1 mapping (15,24), were not employed in the
ause Mortalityns With All-Cause Mortality
ltivariable Analysis 1 Multivariable Analysis 2
usted HR
95% CI) p Value
Adjusted HR
(95% CI) p Value
(1.00–1.08) 0.04 1.04 (1.00–1.07) 0.05
— — — —
— — — —
— — — —
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or coil location relative to the different myocardial
egions being measured. Nevertheless, despite these fac-
ors, we were able to demonstrate a good correlation
etween the amount of MF measured by both methods
nd that their results are significantly related to patient
rognosis after surgery.
F and LV functional improvement. Successful replace-
ent of the aortic valve results in substantial clinical and
emodynamic improvement in patients with severe aortic
alve disease (25,26). However, not all patients respond the
ame way after surgery. Even after a successful procedure,
ome patients will not show any clinical or hemodynamic
mprovement and, not surprisingly, will have a poorer
rognosis. Previous studies have shown that the best pre-
ictor of persistent LV dysfunction after aortic valve re-
lacement is the presence of prolonged LV dysfunction
efore surgery (1,27). As mentioned, there is an inverse
orrelation between the amount of interstitial MF and
esting LV systolic function (1). Nevertheless, the few
tudies that investigated the relationship between the mag-
itude of MF accumulation and LV functional recovery
fter aortic valve replacement have reported conflicting
esults. According to Krayenbuehl et al. (2), the presence of
educed LVEF before valve replacement but not the amount
f interstitial MF was predictive of post-operative LV
ystolic dysfunction. In contrast, according to Hein et al.
1), patients with persistent LV dysfunction after surgery
lso exhibited significantly higher degrees of MF accumu-
ation. In the present study, the follow-up MRI was
erformed over a wide interval after aortic valve replacement
27  22 months). It is possible that this limitation could
ave influenced the results regarding LV functional changes
ver time. Nevertheless, in agreement with Hein et al. (1),
e were able to demonstrate a moderate inverse correlation
etween the amount of MF, either by histopathology or by
e-MRI, and the degree of LV functional improvement
fter aortic valve replacement.
rognostic significance. According to previous registries,
mong patients with aortic stenosis and preserved LV
unction, the operative risk during aortic valve replacement
anges from 2% to 5% in most centers (28). In addition, the
0-year actuarial survival rate of hospital survivors in surgi-
ally treated patients is approximately 85% (29). In the case
f patients with aortic regurgitation, surgical mortality rates
ange from 3% to 8% (28,30), and a late mortality of
pproximately 5% to 10%/year is observed in hospital
urvivors who had prolonged LV dysfunction pre-
peratively (29,31). In the present study, the operative
ortality rate of patients with aortic stenosis was 7%, and
he survival rate of hospital survivors 4.4  1.3 years after
urgery was 85%. Among patients with aortic regurgitation,
urgical mortality rate was 4% and the survival rate of
ospital survivors 4.3  1.5 years after surgery was 64%. As
e can notice, the mortality rates observed in the presenttudy are in agreement with these previous registries, espe-ially if we take into consideration that all patients were
ymptomatic and many also exhibited LV systolic dysfunc-
ion at rest.
Previous studies have shown that the risk factors associ-
ted with higher mortality rates in this patient population
nclude a high NYHA functional class, pre-operative im-
aired LV function, advanced age, and concomitant un-
reated CAD (28–31). This is the first study to demonstrate
hat the amount of MF, either by histopathology or by
e-MRI, is also a predictor of long-term survival after aortic
alve replacement. Indeed, when all the aforementioned
actors (with the exception of concomitant CAD, which was
n exclusion criteria in the present study) were included in
multivariate model, only patient age and the amount of
F remained as independent predictors of late mortality.
t this point, it is important to remember that the number
f events in the present study was relatively small, resulting
n overfitted multivariate models. Therefore, further studies
ith larger cohorts will be necessary to examine in greater
etail the importance of each of these factors as predictors of
ate mortality. Nevertheless, our results indicate that the
uantitative assessment of MF has the potential to provide
dditional prognostic information in the evaluation of pa-
ients with severe aortic valve disease. In the future, this
arker of chronic myocardial injury, which can be nonin-
asively quantified by ce-MRI, might have the potential to
e useful in the difficult decision-making process regarding
he best moment to indicate a valve replacement surgery in
atients with severe aortic valve disease.
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